Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition, making a quick turnaround unlikely. The stock isn’t a screaming value; peers like Cigna and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results